Web Results

Vaso Active Pharmaceuticals, Inc., Debtors, Jeoffrey L. Burtch ...


Aug 11, 2014 ... FOR THE DISTRICT OF DELAWARE. In re: ) Chapter 11. ) VASO ACTIVE PHARMACEUTICALS, INC., ). ) Case No. 10-10855 (CSS). Debtors.

Vaso Active Pharmaceuticals, Inc. : Lit. Rel. No. 18834 / August 17 ...


Aug 17, 2004 ... Litigation Release No. 18834 / August 17, 2004. SEC Files Settled Action Charging Vaso Active Pharmaceuticals, Inc. and its President and ...

Cases | A.B. Data Class Action Administration


Beverly Enterprises - Arkansas, Inc., et al. and Vera Cooney and Eula Mae Allen, et al., v. Beverly ...... In re Vaso Active Pharmaceuticals Securities Litigation.

Protected Graft Copolymer Excipient Leads to a Higher ... - PharmaIN


icity of two nanoformulations of Vasoactive Intestinal Peptide (VIP). Methods VIP was .... mulations is primarily the function of drug:nanocarrier weight ratio or ... PGC was synthesized as described by Castillo et al. (4). Specifi- ... er 20 ml DCM and re-centrifuged. .... performed using GraphPad Prism (GraphPad Software Inc. ,.

Depolarization Increases Vasoactive Intestinal Peptide- and ...


ganglion (SCG) of the adult rat (Hokfelt et al., 1977; Sasek and. Zigmond, 1989). ... synthesis, depolarization of sympathetic neurons has been re- ported to inhibit the .... by adding 1.5 PM veratridine (ICN Pharmaceuticals Inc., Plainview,. NY).

VPAC1 receptor expression in peripheral blood mononuclear cells ...


May 7, 2013 ... Vasoactive intestinal peptide (VIP) exerts immune-modulatory actions mainly .... B according the protocol (Phoenix Pharmaceuticals Inc., Karlsruhe, Germany) and .... It is likely that receptor internalization as described by Langlet et al., [27] is ... As suggested previoulsy [27], recycling and re-organization of ....

Alarin is a vasoactive peptide


Jun 12, 2007 ... The gene of the vasoactive intestinal peptide (VIP) is alternatively spliced .... binding assays were performed according to Berger et al. ... Full-length human galanin was purchased from Phoenix Pharmaceuticals (Belmont, .... Enigk RE ,; Maimone MM ..... Video content is hosted by Glencoe Software, Inc.

Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney


Jul 3, 2016 ... Igaki et al. and Pham et al. reported that the infusion of CNP in rats ... EcoLite, for liquid scintillation, was from ICN Pharmaceutical Inc., CA, USA. ...... and R. E. Pratt, “Identification of 'B' receptor for natriuretic peptide in human ...

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase ...


flammatory cytokines such as IL-6 and TNF (11–13), to re- duce the expression of the .... and H89 was from ICN Pharmaceuticals Inc (Costa Mesa, CA). Anti- bodies against .... pared by the mini-extraction procedure of Schreiber et al. (40) with.

Acute Heart Failure Syndromes and Coronary Perfusion


In AHFS, the relationship among vasoactive medications, coronary perfusion, and ... not been included in the evaluation of vasoactive drug ... pressures, hypotension, and increased contractility in re- ... Published by Elsevier Inc. .... Ng et al. (23) have validated the use of. IMR in the cardiac catheterization laboratory.

More Info

In re Proliance Int'l, Inc. - Weil Bankruptcy Blog


Aug 14, 2014 ... In Re: : : PROLIANCE INTERNATIONAL, INC., et al. : Chapter 7 ...... this ruling in In re Vaso Active Pharmaceuticals, Inc.43 Therein, the.

Vaso Active Pharmaceuticals, Inc.: OTCMKTS:VAPHQ quotes ...


Vaso Active Pharmaceuticals, Inc. is a company focused on commercializing, marketing and selling over-the-counter (OTC) pharmaceutical products. Vaso ...

New Value Does Not Need to Remain Unpaid. - Buchanan Ingersoll ...


Oct 29, 2014 ... In In re Proliance International, Inc., et al., Judge Sontchi of the United ... Design, Inc. and In re Vaso Active Pharmaceuticals, Inc., at lease by.